No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Devices
Suzhou Basecare Medical Corporation Limited, an investment holding company established in Suzhou, China, in 2010, focuses its business activities within the People's Republic of China. The company primarily engages in the research, development, and manufacturing of genetic testing solutions specifically for assisted reproduction, alongside the distribution of related medical devices and instruments. Its extensive product line includes a range of genetic test kits for reproductive health. These comprise pre-implantation genetic tests such as PGT-A, designed to screen for chromosomal aneuploidies; PGT-M, which identifies single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kits, used to detect chromosomal structural rearrangements often linked to recurrent miscarriages. Additionally, Basecare offers prenatal test kits (CNV kits) and postnatal test kits (WES kits). Complementing its genetic testing offerings, the company supplies various specialized medical equipment, including liquid nitrogen storage dewars, cryostorage systems, automated workstations, sperm quality analyzers, and next-generation sequencing (NGS) sequencers. Beyond manufacturing and sales, Basecare also provides marketing services and develops software for its medical devices and instruments. Its primary clientele consists of hospitals and reproductive clinics.
www.basecare.cnNo one on the platform currently holds 2170.HK.
No tracked institution reports a position in 2170.HK as of their last filing.
No one on the platform has traded 2170.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $288M | -19.9% | $-0.59 | $-0.59–$-0.59 | — | 1 |
| 2027 | $321M | +11.7% | $-0.41 | $-0.41–$-0.41 | — | 1 |
| 2028 | $351M | +9.2% | $-0.24 | $-0.24–$-0.24 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 2170.HKSuzhou Basecare Medical Corporation Limited | $1.29 | -0.38% | $354M | — |
| 1612.HKVincent Medical Holdings Limited | $0.67 | +0.00% | $436M | — |
| 1652.HKFusen Pharmaceutical Company Limited | $0.85 | +6.25% | $628M | — |
| 1942.HKMOG Digitech Holdings Limited | $0.07 | +1.41% | $107M | — |
| 2297.HKRainmed Medical Limited | $0.16 | +1.27% | $224M | — |
| 2325.HKYunkang Group Limited | $0.47 | -3.09% | $275M | — |
| 2563.HKBeijing Biostar Pharms Co Ltd | $4.10 | -4.65% | $991M | — |
Source: Financial Modeling Prep · peers by sector/industry